NYSE ARCA | ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 4.19% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.98% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 3.76% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.74% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 3.73% |
| ELVN | Enliven Therapeutics Inc. | Healthcare | Biotechnology | 2.53% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 2.50% |
| OMER | Omeros Corporation | Healthcare | Biotechnology | 2.22% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.12% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.09% |
| TRVI | Trevi Therapeutics Inc | Healthcare | Biotechnology | 2.09% |
| NKTR | Nektar Therapeutics | Healthcare | Biotechnology | 2.06% |
| TERN | Terns Pharmaceuticals Inc | Healthcare | Biotechnology | 2.04% |
| MNMD | Mind Medicine Inc | Healthcare | Biotechnology | 2.01% |
| PCRX | Pacira BioSciences, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 2.01% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 1.99% |
| HROW | Harrow Health Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.98% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 1.95% |
| MAZE | Maze Therapeutics, Inc. Common Stock | Healthcare | Biotechnology | 1.92% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.92% |